CD274 and neoplasm: Recently, novel immune therapy approaches aimed at inducing an immune checkpoint blockade, like treatment with anti-PD1 or anti-PD-L1 antibodies, have gained much interest, but have been successful only in a certain fraction of tumor patients [3], [4], [5], [6], [7].